Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Leonard Braden Michael, Executive. Officer active across 16 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 74 disclosures have been published. Breakdown: 57 buys · 15 sells. Total volume traded: €37.5m. History available since 12 April 2022. The latest transaction was filed on 23 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Leonard Braden Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
167,544 shares@ US$1.29168.0% of flowCommon StockSEC:0001373604-24-000060:0
Canonical exit: 31 Oct 2024 (T+90)
25 of 74 declarations
About Leonard Braden Michael
Michael Braden Leonard is an executive at Gemini Therapeutics, Inc., IMARA Inc., and Retractable Technologies Inc. Although his specific role is not specified, he contributes to the leadership and management of operations at these companies. His experience and skills are essential for the strategic development and achievement of business objectives for these firms.